background
young
children
persist
wheez
pose
diagnost
therapeut
challeng
pediatrician
aim
evalu
bacteri
bronchial
infect
possibl
reason
non
respons
convent
asthma
therapi
identifi
characteris
predomin
pathogen
involv
method
retrospect
analys
microbiolog
cytolog
find
select
popul
young
wheezer
symptom
unrespons
inhal
corticosteroid
ic
therapi
underw
flexibl
bronchoscopi
bronchoalveolar
lavag
bal
procedur
measur
taken
limit
contamin
risk
quantit
bacteri
cultur
bal
fluid
signific
cutoff
colonyform
unitsml
use
modern
microbiolog
method
use
detect
wide
panel
pathogen
characteris
bacteri
isol
result
children
age
month
without
structur
anomali
conduct
airway
evalu
signific
bacteri
bal
cultur
found
patient
haemophilu
influenza
isol
streptococcu
pneumonia
moraxella
catarrhali
h
influenza
isol
nonencapsul
strain
definit
distinguish
nonhaemolyt
h
haemolyticu
respiratori
virus
detect
case
mix
bacterialvir
infect
cytolog
reveal
mark
neutrophil
inflamm
conclus
bacteri
infect
bronchial
tree
common
persist
preschool
wheezer
provid
possibl
explan
non
respons
ic
therapi
nontyp
h
influenza
seem
predomin
pathogen
involv
follow
pneumonia
catarrhali
recurr
andor
persist
wheez
young
children
major
reason
use
pediatr
healthcar
resourc
despit
high
morbid
persist
infantil
wheez
comprehens
studi
domain
result
poor
knowledg
pathophysiolog
lack
efficaci
data
therapeut
intervent
although
pediatr
asthma
phenotyp
describ
daili
practic
preschool
wheezer
remain
diagnost
therapeut
challeng
pediatrician
current
asthma
guidelin
recommend
trial
inhal
corticosteroid
ic
children
base
establish
pathophysiolog
eosinophil
inflamm
proven
efficaci
asthma
adult
clinic
experi
scientif
report
appar
preschool
wheezer
heterogen
group
part
benefit
use
ic
sever
author
recommend
extens
workup
ic
nonrespond
includ
gastrooesophag
reflux
allergi
test
sweat
chlorid
test
bronchoscopi
bronchoalveolar
lavag
fob
bal
evalu
underli
structur
anomali
comorbid
underli
genet
disord
infecti
etiolog
report
describ
find
fob
bal
select
group
young
persist
wheezer
without
underli
structur
anomali
focu
microbiolog
find
discuss
possibl
pathophysiolog
bronchial
bacteri
infect
children
physician
diagnos
persist
wheez
unrespons
ic
therapi
underw
fob
bal
januari
decemb
includ
tertiari
referr
centr
refer
children
evalu
treatment
persist
wheez
despit
ic
treatment
antireflux
therapi
demonstr
gerd
initi
assess
includ
detail
histori
diseas
symptom
sign
treatment
adher
check
appropri
treatment
administr
dosag
thorough
physic
examin
children
without
appar
explan
persist
wheez
workup
includ
fob
bal
conduct
case
fob
bal
alway
perform
stabl
condit
outsid
episod
acut
infect
exacerb
respiratori
symptom
children
symptom
wheez
chronic
wet
cough
recurr
bronchiti
stridor
main
reason
fob
bal
exclud
children
respiratori
tract
anomali
includ
malacia
conduct
airway
known
underli
chronic
condit
cystic
fibrosi
primari
ciliari
dyskinesia
immun
defici
bronchopulmonari
dysplasia
congenit
heart
diseas
neuromuscular
disord
also
exclud
avail
result
allergi
reflux
test
data
antireflux
therapi
prior
fob
bal
famili
histori
allergi
asthma
histori
exposur
tobacco
smoke
respons
antibiot
treatment
record
children
posit
skin
prick
test
andor
elev
specif
immunoglobulin
e
blood
consid
allerg
gerd
assess
posit
houroesophag
ph
measur
interpret
accord
gastroenterolog
criteria
flexibl
fibroscop
bronchoscopi
bronchoalveolar
lavag
fob
balsampl
perform
accord
european
respiratori
societi
recommend
previous
describ
balsampl
divid
aliquot
immedi
sent
microbiolog
lab
hematolog
lab
upon
arriv
lab
balsampl
process
smear
bacteri
cultur
viral
cultur
detect
influenzaviru
b
parainfluenzaviru
type
rsv
human
metapneumoviru
subtyp
b
coronavirus
mycoplasma
pneumonia
chlamydophila
pneumonia
use
inhous
multiplex
polymeras
chain
reaction
mpcr
protocol
describ
previous
perform
test
assess
regular
particip
extern
qualiti
programm
organis
qcmd
west
scotland
scienc
park
glasgow
scotland
uk
gram
stain
smear
bacteri
balcultur
perform
accord
standard
method
balfluid
centrifug
cytospin
slide
gram
stain
sampl
consid
repres
lower
airway
instil
volum
recov
nucleat
cell
squamou
epitheli
cell
smear
undilut
dilut
balfluid
inocul
blood
agar
supplement
x
v
factor
incub
co
macconkey
agar
mannitol
salt
agar
incub
air
growth
assess
h
h
case
growth
h
result
report
semiquantit
term
growth
potenti
pathogen
cfuml
consid
signific
h
influenza
pneumonia
isol
sent
respect
belgian
refer
lab
capsular
type
describ
elsewher
nthi
isol
discrimin
nonhaemolyt
haemophilu
haemolyticu
nonhaemolyt
h
haemolyticu
use
molecular
techniqu
cytolog
balfluid
transport
laboratori
silicon
contain
ice
fluid
filter
nylon
gauz
stain
brilliant
cresyl
blue
total
nuclear
cell
count
perform
count
chamber
light
microscopi
magnif
cell
suspens
cell
made
phosphatebuff
salin
bovin
serum
albumin
pbsbsa
cytocentrifug
prepar
made
stain
giemsa
two
hundr
cell
examin
differenti
cell
count
given
median
percentag
neutrophil
balfluid
healthi
children
chose
base
definit
neutrophil
inflamm
balfluid
presenc
neutrophil
cytolog
differenti
previous
done
saito
et
al
statist
analys
perform
use
spss
ibm
statist
version
softwar
mannwithney
test
use
equal
median
pvalu
consid
statist
signific
multipl
comparison
handl
holm
method
case
fob
bal
medic
indic
full
parent
consent
obtain
oral
explan
procedur
benefit
risk
retrospect
chart
analysi
approv
ethic
committe
universitair
ziekenhui
brussel
uz
brussel
thirtythre
children
girl
boy
median
age
month
rang
assess
unexplain
persist
wheez
despit
ic
therapi
administr
ic
dosag
rang
mcg
fluticason
daili
equival
variabl
treatment
durat
month
tabl
summaris
characterist
studi
popul
respect
allergi
reflux
test
result
famili
environment
risk
factor
asthma
children
suffer
gastrooesophag
reflux
diseas
gerd
treat
gerd
prior
fob
bal
none
children
treat
antibiot
day
prior
fob
bal
fob
bal
procedur
well
toler
children
signific
bacteri
cultur
found
children
tabl
signific
differ
number
posit
balcultur
seen
children
without
gerd
aerob
bacteria
isol
sole
pathogen
case
mix
bacterialvir
infect
mix
bacterialatyp
infect
found
case
respect
tabl
consid
signific
bacteri
balcultur
haemophilu
influenza
h
influenza
isol
children
predomin
bacteria
found
follow
streptococcu
pneumonia
pneumonia
moraxella
catarrhali
catarrhali
tabl
bacteri
coinfect
found
case
includ
h
influenza
twice
pneumonia
catarrhali
pneumonia
catarrhali
coinfect
staphylococcu
aureu
serratia
marcescen
tabl
respiratori
virus
detect
case
predomin
respiratori
syncyti
viru
rsv
tabl
case
respiratori
viru
sole
pathogen
detect
tabl
mycoplasma
pneumonia
detect
case
mix
infect
h
influenza
tabl
capsular
type
h
influenza
isol
reveal
isol
nonencapsul
strain
nthi
nthi
strain
evalu
misidentif
nonhaemolyt
h
haemolyticu
proven
true
nthi
nine
ten
nthi
isol
neg
suscept
ampicillin
mic
cefuroxim
mic
latter
isol
posit
mic
amoxicillinclavulan
mic
cefuroxim
pneumonia
isol
fulli
suscept
penicillin
belong
serogroup
st
st
st
st
suscept
base
antibiot
treatment
patient
signific
balcultur
routin
centr
gener
antibiot
administ
oral
day
daili
dose
mgkg
amoxicillin
amoxicillinclavulan
patient
respond
well
treatment
chang
symptom
note
data
miss
patient
respond
howev
symptom
relaps
within
week
complet
antibiot
treatment
one
patient
fob
bal
repeat
day
initi
procedur
nthi
coloni
form
unit
cfu
ml
present
sole
pathogen
first
bal
fluid
cultur
togeth
pneumonia
cfuml
total
cell
count
tcc
balfluid
high
median
iqr
differenti
cytolog
reveal
neutrophil
inflamm
patient
patient
posit
bacteri
balcultur
significantli
higher
ttc
median
iqr
versu
iqr
mm
p
compar
patient
neg
balcultur
cytolog
balfluid
differ
significantli
patient
nthi
isol
bal
patient
neg
balcultur
tabl
contrast
viral
infect
known
associ
wheez
young
children
bacteri
infect
long
consid
import
asthma
wheez
antibiot
therapi
recommend
current
asthma
treatment
guidelin
howev
sever
studi
suggest
bacteria
might
play
role
wheez
young
children
moreov
increasingli
appreci
human
bodi
home
extend
microbiom
asthmat
children
harbour
differ
bacteria
less
divers
mix
compar
healthi
children
characteris
predomin
bacteria
wheez
children
essenti
understand
pathophysiolog
persist
wheez
recent
tracheobronchomalacia
shown
highli
associ
bronchial
inflamm
bacteri
infect
children
persist
respiratori
symptom
nevertheless
remain
unclear
whether
bacteri
infect
simpli
consequ
impair
mucociliari
clearanc
whether
independ
inflammatori
stimulu
persist
wheezer
hypothes
bacteri
infect
might
inde
independ
inflammatori
stimulu
persist
preschool
wheezer
chose
studi
select
group
patient
without
structur
anomali
conduct
airway
studi
found
bronchial
bacteri
infect
common
persist
preschool
wheezer
without
appar
reason
impair
mucociliari
clearanc
h
influenza
predomin
aerob
pathogen
isol
follow
pneumonia
catarrhali
also
found
frequent
bacteri
coinfect
involv
pathogen
find
corrobor
observ
author
also
describ
predomin
bacteri
triad
children
persist
recurr
wheez
frequent
upper
respiratori
tract
colonis
aerob
bacteria
children
may
provid
difficulti
discrimin
contamin
true
bronchial
infect
howev
consid
result
reflect
true
bronchial
infect
appli
procedur
method
shown
limit
strongli
risk
contamin
particular
chose
use
cutoff
cfuml
bacteri
balcultur
although
adult
cutoff
cfuml
demonstr
discrimin
appli
cutoff
also
use
previous
other
studi
children
chronic
bronchiti
moreov
although
fob
bal
perform
major
patient
result
probabl
reflect
chronic
bronchial
infect
sampl
collect
stabl
clinic
state
presenc
signific
increas
neutrophil
inflamm
balfluid
patient
nthi
cultur
compar
patient
neg
balcultur
support
hypothesi
bacteri
infect
inde
inflammatori
stimulu
children
persist
wheez
h
influenza
predomin
aerob
bacteri
pathogen
isol
patient
although
previous
author
similar
result
isol
strain
h
influenza
never
characteris
knowledg
first
report
associ
bronchial
infect
nontyp
h
influenza
nthi
young
persist
wheezer
identif
nthi
predomin
pathogen
support
hypothesi
persist
wheezer
present
underli
inflamm
induc
chronic
bacteri
infect
chronic
nthi
infect
result
abil
nthi
persist
lower
airway
sever
escap
mechan
host
immun
respons
previous
report
other
moreov
lower
airway
patient
chronic
obstruct
lung
diseas
nthi
demonstr
major
inflammatori
stimulu
poor
respons
symptom
invitro
suscept
guid
adequ
dose
antibiot
treatment
found
similar
poor
respons
find
diseas
entiti
involv
h
influenza
predomin
pathogen
children
recurr
unrespons
otiti
media
protract
bacteri
bronchiti
middl
ear
biofilm
format
demonstr
one
major
mechan
persist
provid
explan
unrespons
antibiot
therapi
moreov
biofilm
format
intracellular
infect
well
establish
mechan
nthi
persist
lower
airway
although
studi
provid
evid
biofilm
format
lower
airway
young
unrespons
wheezer
find
poor
respons
frequent
relaps
short
cours
antibiot
treatment
suggest
involv
biofilm
biofilm
format
address
futur
studi
presenc
may
consequ
treatment
strength
studi
exhaust
microbiolog
evalu
use
semiquantit
balcultur
multiplexpcr
mpcr
viral
atyp
agent
thorough
characteris
isol
h
influenza
strain
howev
may
miss
case
viral
infect
human
rhinoviru
includ
appli
pcrprotocol
major
weak
studi
retrospect
charact
absenc
agematch
control
group
howev
report
prospect
conduct
studi
without
profound
characteris
isol
describ
associ
wheez
bacteri
infect
support
find
absenc
control
group
consid
minor
weak
previou
public
demonstr
limit
risk
contamin
bal
technic
precaut
taken
moreov
perform
fob
bal
consid
uneth
healthi
children
anoth
limit
small
patient
cohort
due
multipl
exclus
criteria
appli
patient
includ
analysi
repres
children
seen
clinic
persist
respiratori
symptom
nevertheless
analysi
highli
select
popul
without
structur
caus
impair
mucu
clearanc
enabl
us
evalu
associ
bacteri
bronchial
infect
neutrophil
inflamm
symptom
resist
ic
therapi
preschool
children
persist
wheez
unrespons
adequ
inhal
asthma
treatment
bacteri
infect
frequent
nthi
pneumonia
catarrhali
main
pathogen
involv
microbiolog
find
presenc
pronounc
neutrophil
inflamm
balfluid
sampl
patient
present
acut
exacerb
episod
favour
hypothesi
chronic
bacteri
infect
ongo
inflammatori
stimulu
provid
possibl
explan
persist
wheez
despit
ic
therapi
young
patient
element
suggest
use
antibiot
treatment
although
current
recommend
consid
select
young
children
present
chronic
wheez
howev
patient
indistinguish
without
use
invas
procedur
biofilm
format
escap
mechan
may
decreas
bactericid
efficaci
antibiot
treatment
addit
research
necessari
specif
treatment
recommend
provid
futur
research
focu
popul
characterist
determin
risk
factor
acquisit
bacteri
bronchial
infect
pathogen
mechan
chronic
bronchial
infect
possibl
prevent
treatment
strategi
